BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25320503)

  • 1. Proteomic and metabolic prediction of response to therapy in gastric cancer.
    Aichler M; Luber B; Lordick F; Walch A
    World J Gastroenterol; 2014 Oct; 20(38):13648-57. PubMed ID: 25320503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized medicine in gastric cancer: Where are we and where are we going?
    Jácome AA; Coutinho AK; Lima EM; Andrade AC; Dos Santos JS
    World J Gastroenterol; 2016 Jan; 22(3):1160-71. PubMed ID: 26811654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the development of protein biomarkers of oesophageal and gastric cancers.
    Coghlin C; Murray GI
    Proteomics Clin Appl; 2016 Apr; 10(4):532-45. PubMed ID: 26582241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
    Joo MK; Park JJ; Chun HJ
    World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
    Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M
    World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Companion diagnostics for the targeted therapy of gastric cancer.
    Yoo C; Park YS
    World J Gastroenterol; 2015 Oct; 21(39):10948-55. PubMed ID: 26494953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug sensitivity testing platforms for gastric cancer diagnostics.
    Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
    J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing strategies for target therapy in gastric cancer.
    Lee SY; Oh SC
    World J Gastroenterol; 2016 Jan; 22(3):1179-89. PubMed ID: 26811656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.
    Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K
    World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging therapies in unresectable and recurrent gastric cancer.
    Jou E; Rajdev L
    World J Gastroenterol; 2016 May; 22(20):4812-23. PubMed ID: 27239108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic biomarker predicts therapeutical effects of oxaliplatin combining with fluoropyrimidine in metastatic gastric cancer patients by the SELDI-proteinchip platform.
    Yu Z; Yu JK; Fang XF; Yuan Y; Shen H
    Hepatogastroenterology; 2013 Oct; 60(127):1800-4. PubMed ID: 24624447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.
    Matboli M; El-Nakeep S; Hossam N; Habieb A; Azazy AE; Ebrahim AE; Nagy Z; Abdel-Rahman O
    World J Gastroenterol; 2016 Jul; 22(26):5896-908. PubMed ID: 27468184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
    Shin VY; Chu KM
    World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine.
    Wang S; Yuan L
    Biosci Trends; 2016 Jul; 10(3):171-80. PubMed ID: 27251446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncoproteomics: Trials and tribulations.
    Zhou L; Li Q; Wang J; Huang C; Nice EC
    Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies.
    Ott K; Lordick F; Herrmann K; Krause BJ; Schuhmacher C; Siewert JR
    Gastric Cancer; 2008; 11(1):1-9. PubMed ID: 18373171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic studies of human gastric cancer: review.
    Jayavelu ND; Bar NS
    World J Gastroenterol; 2014 Jul; 20(25):8092-101. PubMed ID: 25009381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards personalized perioperative treatment for advanced gastric cancer.
    Miao RL; Wu AW
    World J Gastroenterol; 2014 Sep; 20(33):11586-94. PubMed ID: 25206266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose metabolism in gastric cancer: The cutting-edge.
    Yuan LW; Yamashita H; Seto Y
    World J Gastroenterol; 2016 Feb; 22(6):2046-59. PubMed ID: 26877609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.